HealthCanadaWambaugh03115-draft.pptx (13.73 MB)

Exposure and Dosimetry Considerations for Adverse Outcome Pathways

presentation

posted on 2017-06-30, 13:51 authored by John Wambaugh, 0000-0002-4024-534X

Presented at the Application of New Methods in Risk Science in Regulatory Decision-Making Regarding Chemical Substances

History

Usage metrics

Categories

Toxicology (incl. clinical toxicology)

Keywords

Dosimetry Exposure High Throughput Toxicokinetics (HTTK)CompTox Toxicology

Licence

Exports